Clinical Trials
All Clinical Trials - Page 17 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT06300216N/ANot Yet Recruiting
A Real-world Study of Octreotide Microspheres in Chinese Patients With Neuroendocrine Tumors
Octreotide
- NCT06420739N/AActive Not Recruiting
The Semaglutide Study
Semaglutide
- NCT06313528Phase 1Completed
A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943
Retatrutide
- NCT06324461Phase 4Recruiting
GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery
Dulaglutide
- NCT06323174Phase 3Completed
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
Semaglutide
- NCT06326047Phase 2Completed
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes
Tirzepatide
- NCT06326060Phase 2Completed
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight
Tirzepatide
- NCT06297603Phase 3Active Not Recruiting
Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)
Retatrutide
- NCT06200467Phase 1Completed
A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity
Survodutide
- NCT06301256N/AUnknown
Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe HS Hidradenitis Suppurativa
Tirzepatide
- NCT06388642Phase 1/Phase 2Completed
Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients
Afamelanotide
- NCT06277336N/ACompleted
Effects of Intravenous [Pyr1]Apelin-13 on Healthy Volunteers With Artificially Induced SIAD
Desmopressin
- NCT06290453N/AUnknown
The Regulatory Role of miRNA 27 Follistatin Like Protein-1 Gene in Multiple Scelerosis
Follistatin
- NCT06184568Phase 3Completed
A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity
Semaglutide
- NCT05827081Phase 3Recruiting
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Gonadorelin
- NCT06289504Phase 1Completed
A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight
Semaglutide
- NCT06161844Phase 3Completed
Efficacy and Safety of Semaglutide Injection (HD1916) in Patients With Type 2 Diabetes Mellitus
Semaglutide
- NCT06207877Phase 1Completed
A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body Weight
Semaglutide
- NCT06285006N/AUnknown
Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis
Desmopressin
- NCT06260722Phase 3Active Not Recruiting
Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)
Retatrutide
- NCT06269107Phase 3Completed
A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)
Semaglutide
- NCT06267092Phase 1Completed
A Study of How CagriSema Works on Appetite in People With Excess Body Weight
Semaglutide
- NCT06186063N/AUnknown
The Role of Amylin in Bone Metabolism
Pramlintide
- NCT06193616N/AActive Not Recruiting
Outcome of ADPKD With Octreotide LAR
Octreotide
- NCT06240039N/AActive Not Recruiting
Direct Versus Indirect Effect of Amino Acids on Hepatokines
Octreotide
- NCT06169124Phase 2Active Not Recruiting
Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors
Gonadorelin
- NCT06901648Phase 2Completed
A Study of HS-20094 in Patients With T2DM
Dulaglutide
- NCT06214741Phase 3Completed
A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight
Survodutide
- NCT06243536Phase 4Unknown
The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients
Semaglutide
- NCT07128394N/ARecruiting
Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment
Gonadorelin
- NCT06264609Phase 4Enrolling By Invitation
Precision Medicine Approach for Osteoporosis - Follow Up Study
Teriparatide
- NCT06154187Phase 3Unknown
Study to Evaluate the Efficacy and Safety of PBK_L2201 in Postmenopausal Women With Osteoporosis
Abaloparatide
- NCT06072963Phase 2Recruiting
COMMETS- Combination MCI Metabolic Syndrome
Semaglutide
- NCT05746039Phase 1/Phase 2Recruiting
Feasibility of Semaglutide in Advanced Lung Disease
Semaglutide
- NCT06083675Phase 3Withdrawn
Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes
Semaglutide
- NCT06171152EARLY_Phase 1Suspended
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
Liraglutide
- NCT05896566Phase 2Completed
A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer
Sermorelin
- NCT06699329Phase 1Completed
A Study of Enlicitide Decanoate (MK-0616) and Semaglutide in Healthy Adult Participants (MK-0616-023)
Semaglutide
- NCT06221969Phase 3Completed
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
Tirzepatide
- NCT06176365Phase 3Completed
A Study to Test Whether Survodutide Helps Japanese People Living With Obesity Disease
Survodutide
- NCT05999968Phase 1Terminated
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment
Gonadorelin
- NCT05780905Phase 4Recruiting
Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
Semaglutide
- NCT06192108Phase 3Completed
A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin
Orforglipron
- NCT06375707Phase 2Completed
First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/HER2-Negative Advanced Breast Cancer
Gonadorelin
- NCT06056804Phase 2Active Not Recruiting
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer
Thymosin-Alpha-1
- NCT05708859Phase 4Recruiting
Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
Tirzepatide
- NCT06351748N/ACompleted
Real-world Study of CHina Ozempic cLinicAl pRactice in Patients With Type 2 Diabetes (SCHOLAR)
Semaglutide
- NCT06525155Phase 3Recruiting
Effect GnRH Agonist Administration in Endometriosis Cyst Patients
Gonadorelin
- NCT06186622Phase 1Completed
A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants
Orforglipron
- NCT07701005N/ACompleted
Non-Invasive Hepatic and Metabolic Index Changes After Incretin Therapy in Overweight/Obesity
Tirzepatide